000			01528 a2200409 4500
005			20250513033513.0
264		0	_c19951215
008			199512s 0 0 eng d
022			_a0022-3042
024	7		_a10.1046/j.1471-4159.1995.65062432.x _2doi
040			_aNLM _beng _cNLM
100	1		_aMyers, K M
245	0	0	_aBcl-2 protects neural cells from cyanide/aglycemia-induced lipid oxidation, mitochondrial injury, and loss of viability. _h[electronic resource]
260			_bJournal of neurochemistry _cDec 1995
300			_a2432-40 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aGlucose _xdeficiency
650	0	4	_aLipid Metabolism
650	0	4	_aMice
650	0	4	_aMitochondria _xdrug effects
650	0	4	_aNeurons _xdrug effects
650	0	4	_aNeuroprotective Agents _xpharmacology
650	0	4	_aOxidation-Reduction _xdrug effects
650	0	4	_aPotassium Cyanide _xantagonists & inhibitors
650	0	4	_aProto-Oncogene Proteins _xpharmacology
650	0	4	_aProto-Oncogene Proteins c-bcl-2
650	0	4	_aTumor Cells, Cultured
700	1		_aFiskum, G
700	1		_aLiu, Y
700	1		_aSimmens, S J
700	1		_aBredesen, D E
700	1		_aMurphy, A N
773	0		_tJournal of neurochemistry _gvol. 65 _gno. 6 _gp. 2432-40
856	4	0	_uhttps://doi.org/10.1046/j.1471-4159.1995.65062432.x _zAvailable from publisher's website
999			_c7594976 _d7594976